Biological Engineering · established service line
Synthetic Biology and Genome Engineering
The design or modification of genes, cells, organisms, biological circuits, and metabolic pathways for medicine, manufacturing, agriculture, sensing, and environmental applications.
Section A
Scientific Mission
Structure causal evidence and approved experiments without crossing biosafety or operational boundaries.
Section B
Typical Research Questions
- What evidence supports each proposed causal pathway and construct decision?
- Which off-target, batch, and failure mechanisms remain live?
- Which approved experiment best reduces uncertainty without bypassing biosafety review?
Section C
Participating Laboratory Types
- CRISPR groups
- Metabolic-engineering teams
- Cellular-engineering labs
- Biofoundries
- Microbiology laboratories
- Systems-biology groups
- Biomanufacturing programs
Section D
Approved Input Schema
Only approved, provenance-bearing materials enter the engagement. Intake confirms ownership, handling class, access, completeness, and permitted use.
- Genomic data and pathway models
- Construct designs, assay results, and phenotype data
- Transcriptomics, proteomics, metabolomics, and off-target analyses
- Protocol histories, batch records, and biosafety constraints
Section E
Recommended KRYOS v6 Stack
- 01 · KX-01Scientific Evidence Intake Kernel
- 02 · KX-02Source-Grounded Research Ontology
- 03 · KX-07Bayesian Active Experiment Planner
- 04 · KX-06Deep Forensics and Artifact Elimination System
- 05 · KX-13Dual-Use / Compliance Gate
- 06 · KX-12Cross-Lab Replication Packet Generator
Section F
Exact Engagement Sequence
Register sources, owners, dates, and handling classification.
- Required inputs
- Approved source inventory with handling classes
- Anticipated artifact
- Source register
- Human gate
- Compliance Lead confirms every source is cleared for the engagement.
- Pause condition
- Material appears outside the approved handling class.
Service-specific emphasis
- Register biological entities, constructs, assays, batches, and provenance.
- Model causal pathways while preserving competing and off-target hypotheses.
- Rank approved experiments through safety, dual-use, and information-gain gates.
- Preserve complete decision, failure, and replication records.
Section G
Common Confounders and Failure Modes
- Batch effects
- Off-target effects
- Contamination
- Assay bias
- Context-dependent phenotype
Section H
Anticipated Output Architecture
Service emphasis: Source-grounded pathway map · Construct evidence register · Off-target risk report · Causal hypothesis table · Experiment queue · Phenotype analysis · Design revision plan · Biosafety gate · Reproducible research packet
- What the laboratory receives
- Current supported position with limitations
- Evidence state required
- Document-Supported
- Who reviews it
- Lab Director
- Decision supported
- Continue, pause, or escalate
Section I
Scientific Boundary
Section J
Human Review and Governance
- Qualified biological reviewers approve ontology and causal assumptions.
- Biosafety and dual-use authorities approve every proposed experimental progression.
- The principal investigator retains responsibility for all laboratory decisions.
No autonomous binding decision is issued. Null results, contradictions, provenance gaps, and review dissent remain in the record.
Section K
Related Domains
Section L
Request Pilot Review
Begin with non-sensitive qualification. Approved inputs, access, confidentiality, safety, compliance, and review ownership are established before research materials enter the engagement.